BURLINGTON, Mass. — March 4, 2026 — Leads & Copy — Minerva Neurosciences, Inc. (Nasdaq: NERV), a biopharmaceutical company focused on therapies for central nervous system disorders, announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Citizens Life Sciences Conference in Miami, FL, being held March 10-11, 2026.
The Citizens Life Sciences Conference will feature a company presentation on Tuesday, March 10 at 9:35 AM ET.
A live webcast of the presentation can be found at: https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/SKrutqyvQVtnaKJDseE6uU.
Those interested in meeting with the Minerva team during the conference are encouraged to contact their Citizens Bank representative.
A replay of the presentation will be available on the Company’s Investors & Media Events and Presentations webpage for ninety days following the event.
Minerva Neurosciences, Inc. is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia.
Source: Minerva Neurosciences
